1. 49P Thromboembolic risk assessment in patients receiving combination of anti-angiogenic plus anti-PD1 or anti-PD-L1: A descriptive study. (15th December 2019) Authors: Bravo, P; Vss, B; Baldini, C; Romano, P Martin; Hollebecque, A; Varga, A; Vuagnat, P; Champiat, S; Marabelle, A; Escudier, B; Albiges, L; Loriot, Y; Massard, C; Cataldi, A; Babai, S; Voisin, A-L; Lambotte, O; Annereau, M; Michot, J-M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗